Pediatric Cancer News and reporting on pediatric cancer. Oct 7, 2022 Swiss Biotech PreComb Therapeutics Wants to Automate Functional Precision Medicine Premium Aug 18, 2022 CHOP, NCI Launch Big Data Resource to Spur Precision Pediatric Cancer Drug Development Premium Aug 4, 2022 Massey Cancer Center Researchers Exploring SHP2 Inhibitor Potential in Pediatric Neuroblastoma Premium Jul 15, 2022 Pfizer's Xalkori Gets FDA Approval for ALK-Positive Inflammatory Myofibroblastic Tumors Jul 12, 2022 NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling Jul 6, 2022 Structural Variant Study Points to Pediatric Glioma Drivers, Prognostic Features Jun 16, 2022 Day One Bio Raises $150M in Public Offering of Common Stock Jun 14, 2022 Day One Bio's Tovorafenib Market Prospects Look Promising Based on Pediatric Glioma Trial Data Premium Jun 14, 2022 Day One Seeks to Raise $125M in Common Stock Offering Jun 6, 2022 With ASCO Data, Novartis' Tafinlar-Mekinist Heads Toward FDA for BRAF-Mutant Pediatric Brain Cancer Premium May 20, 2022 MSK Starts Offering Pediatric Cancer Patients Whole-Genome, Transcriptome Sequencing Premium Apr 29, 2022 St. Jude Program Installing Nanopore Sequencing in Low-Income Countries to Diagnose Pediatric Blood Cancers Premium Apr 20, 2022 Chinese Regulators Clear JW Therapeutics' Carteyva IND for Pediatric ALL Apr 20, 2022 Proof-of-Principle Study Points to Possibility of Monitoring Pediatric ALL With Plasma Samples Apr 13, 2022 RACE for Children Act Spurs Pharma to Study Molecularly Informed Drugs in Pediatric Cancer Patients Premium Apr 12, 2022 New Epigenomic Biomarker Could Predict CAR T-Cell Therapy Resistance in Advanced Childhood Leukemia Premium Mar 25, 2022 Initial KidsCanSeq Findings Reveal Medical Recommendations Stemming From Germline Tests Mar 21, 2022 NIH Launches New Childhood Cancer Genomics Program Mar 9, 2022 Cellevolve Bio, Seattle Children's Therapeutics Ink CAR-T Pact Focused on Pediatric Brain Cancer Feb 15, 2022 Lantern Pharma Working With Greehey Children's Cancer Research Institute To ID New Uses for Drugs Load More Breaking News Dragonfly Therapeutics Begins Phase II Trial of HER2-Targeted NK-Cell Engager Touchlight to Provide DNA Vector for Odimma Therapeutics' Personalized Neoantigen Vaccine Trial FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement Akeso, Summit Therapeutics Ink $5B Licensing Deal for PD-1/VEGF Bispecific Antibody Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients
